Literature DB >> 20191224

What factors affect the quality of life of patients with keloids?

Fabianne Furtado1, Bernardo Hochman, Soraia Francisco Ferrara, Gal Moreira Dini, José Mário Camelo Nunes, Yara Juliano, Lydia Masako Ferreira.   

Abstract

OBJECTIVE: To evaluate factors that affect the quality of life (QoL) of patients with keloids.
METHODS: A study was conducted on 102 patients of both genders between 15 and 70 years old. During initial evaluation, clinical factors, such as keloid visibility, duration and evolution of the disease, previous treatments, types of treatments and recurrence were recorded. Later, patients responded to the QualiFibro questionnaire, which is specific for evaluation of the QoL of patients with keloids and comprises the physical and psychological domains, and six visual numeric scales (VNS), of which three are related to psychological factors (satisfaction with appearance, shame of the disease, and suffering experienced), and the other three are related to physical factors (pruritus, pain and movement restriction).
RESULTS: Patients with keloids on non-visible areas of the body (p<0.01) and more than 10 years of disease (p<0.049) reported higher scores on the physical domain of the QualiFibro questionnaire, indicating increased severity compared with patients with keloids on visible areas of the body and disease duration of less than 10 years. There was a positive correlation between psychological (satisfaction with appearance, feelings of embarrassment about the disease and suffering experienced) and physical factors (pruritus, pain and movement restriction) evaluated using the VNSs, and both domains of the QualiFibro questionnaire.
CONCLUSION: Results indicate that the physical domain of the QualiFibro questionnaire was the most affected in patients with keloids on non-visible areas and in those with keloids for more than 10 years. Psychological and physical factors associated with keloids as assessed with the VNS affected both psychological and physical domains of QoL.

Entities:  

Mesh:

Year:  2009        PMID: 20191224     DOI: 10.1590/s0104-42302009000600014

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  5 in total

Review 1.  New approach to the understanding of keloid: psychoneuroimmune-endocrine aspects.

Authors:  Bernardo Hochman; Felipe Contoli Isoldi; Fabianne Furtado; Lydia Masako Ferreira
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-02-10

2.  Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids.

Authors:  Michel Pavelecini; Cláudio G Zettler; Marilda C Fernandes; Pedro B Ely
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-02-12

3.  Tomotherapy as an Alternative Irradiative Treatment for Complicated Keloids.

Authors:  Yu-Fang Lin; Pei-Wei Shueng; Tyng-Luen Roan; Dun-Hao Chang; Yen-Chen Yu; Che-Wei Chang; An-Ta Kuo; Yo-Shen Chen; Hsiu-Wen Hsiao; Hui-Ju Tien; Chen-Hsi Hsieh
Journal:  J Clin Med       Date:  2020-11-20       Impact factor: 4.241

4.  Immediate Postoperative Treatment of Keloids with Intraoperative Radiation Therapy Technology: A Pilot Study.

Authors:  Marco Mario Tresoldi; Giovanni Battista Ivaldi; Patrizia Porcu; Fabio Randisi; Andrea Cartocci; Alberto Malovini; Angela Faga; Giovanni Nicoletti
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-09-17

5.  A new treatment of hypertrophic and keloid scars with combined triamcinolone and verapamil: a retrospective study.

Authors:  S B Kant; E van den Kerckhove; C Colla; S Tuinder; R R W J van der Hulst; A A Piatkowski de Grzymala
Journal:  Eur J Plast Surg       Date:  2017-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.